Tech Company Financing Transactions

Oxford Cancer Analytics Funding Round

Oxford Cancer Analytics closed a $11 million Series A funding round on 1/9/2025. Investors included Cross-Border Impact Ventures, WE Ventures and Civilization Ventures.

Transaction Overview

Announced On
1/9/2025
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to develop and globally commercialize its new generation of minimally invasive liquid biopsy blood tests for the early detection of lung cancer.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
Oxford, Undisclosed
UK
Phone
Undisclosed
Email Address
Not Recorded
Overview
Oxford Cancer Analytics, an Oxford, UK- and Toronto, Canada-based medtech company developing blood tests for early cancer detection using proteomics and AI.
Profile
Oxford Cancer Analytics LinkedIn Company Profile
Social Media
Oxford Cancer Analytics Company Twitter Account
Company News
Oxford Cancer Analytics News
Facebook
Oxford Cancer Analytics on Facebook
YouTube
Oxford Cancer Analytics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Peter Liu
  Peter Liu LinkedIn Profile  Peter Liu Twitter Account  Peter Liu News  Peter Liu on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/9/2025: Air venture capital transaction
Next: 1/9/2025: Biosphere venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary